Clostridium difficile ribotype does not predict severe infection

Clinical Infectious Diseases

Volumn 55, Issue 12, 2012, Pages 1661-1668

  Walk, Seth T ^a,b   Micic, Dejan ^a   Jain, Ruchika ^a,b   Lo, Eugene S ^a   Trivedi, Itishree ^a   Liu, Eugene W ^a   Almassalha, Luay M ^a   Ewing, Sarah A ^a   Ring, Cathrin ^a,b   Galecki, Andrzej T ^a,b   Rogers, Mary A M ^a   Washer, Laraine ^a,b   Newton, Duane W ^b   Malani, Preeti N ^a,b,c   Young, Vincent B ^a,b   Aronoff, David M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; FECES ANALYSIS; GENOTYPING TECHNIQUE; HUMAN; INFANT; LEUKOCYTE COUNT; MICROBIAL GENETICS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RIBOTYPE; SCHOOL CHILD; SCREENING; VIRULENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CROSS-SECTIONAL STUDIES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MICHIGAN; MIDDLE AGED; ODDS RATIO; REPRODUCIBILITY OF RESULTS; RIBOTYPING;

EID: 84870192206     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis786     Document Type: Article

References (39)

1. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366:1079-84.
2. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-41.
3. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47:1162-70.
4. Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007; 45:222-7. (Pubitemid 47041014)
5. Akerlund T, Svenungsson B, Lagergren A, Burman LG. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-Associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 2006; 44:353-8. (Pubitemid 43222222)
6. Stabler RA, Dawson LF, Phua LT, Wren BW. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J Med Microbiol 2008; 57:771-5. (Pubitemid 351842071)
7. Merrigan M, Venugopal A, Mallozzi M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 2010; 192:4904-11.
8. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol 2009; 7:868-73 e2.
9. Goldenberg SD, French GL. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect 2011; 62:355-62.
10. Morgan OW, Rodrigues B, Elston T, et al. Clinical severity of Clostridium difficile PCR ribotype 027: A case-case study. PLoS One 2008; 3: E1812.
11. Venugopal AA, Riederer K, Patel SM, et al. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting. Scand J Infect Dis 2011; 44:243-9.
12. Verdoorn BP, Orenstein R, Rosenblatt JE, et al. High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 2010; 66:24-8.
13. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-Associated disease. Infect Control Hosp Epidemiol 2007; 28:140-5. (Pubitemid 46374153)
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-83.
15. Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect 2011; 79:359-63.
16. Sorg JA, Dineen SS. Laboratory maintenance of Clostridium difficile. Curr Protoc Microbiol 2009; Chapter 9:Unit9A 1.
17. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-Targeted primers for quantification of pathogenic and indigenous bacteria in fecal samples by real-Time PCR. J Appl Microbiol 2004; 97:1166-77.
18. Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect 2008; 14:1057-64.
19. Walk ST, Jain R, Trivedi I, et al. Non-Toxigenic Clostridium sordellii: Clinical and microbiological features of a case of cholangitis-Associated bacteremia. Anaerobe 2011; 17:252-6.
20. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002; 40:3470-5. (Pubitemid 34977470)
21. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28:2731-9.
22. Curry SR, Marsh JW, Muto CA, O'Leary MM, Pasculle AW, Harrison LH. tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 2007; 45:215-21.
23. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 1999; 175:261-6. (Pubitemid 29352246)
24. Cheknis AK, Sambol SP, Davidson DM, et al. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe 2009; 15:230-3.
25. Indra A, Huhulescu S, Schneeweis M, et al. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol 2008; 57:1377-82.
26. R Project. R: A Language and environment for statistical computing. Available at: Http://www.R-project.org/.
27. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospitalacquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004; 189:1585-9. (Pubitemid 38648285)
28. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409-15.
29. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136:1913-24.
30. Bacci S, Molbak K, Kjeldsen MK, Olsen KE. Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis 2011; 17:976-82.
31. Geric B, Johnson S, Gerding DN, Grabnar M, Rupnik M. Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 2003; 41:5227-32.
32. Sirard S, Valiquette L, Fortier LC. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulenceassociated phenotypes. J Clin Microbiol 2011; 49:4040-6.
33. Wilson V, Cheek L, Satta G, et al. Predictors of death after Clostridium difficile infection: A report on 128 strain-Typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010; 50: E77-81.
34. Bishara J, Peled N, Pitlik S, Samra Z. Mortality of patients with antibiotic-Associated diarrhea: The impact of Clostridium difficile. J Hosp Infect 2008; 68:308-14.
35. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010; 31:1030-7.
36. Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-Acquired Clostridium difficile infection: A populationbased study. Am J Gastroenterol 2012; 107:89-95.
37. Cadena J, Thompson GR 3rd, Patterson JE, et al. Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci 2010; 339:350-5.
38. Hardt C, Berns T, Treder W, Dumoulin FL. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-Associated diarrhea: Importance of co-morbidity and serum C-reactive protein. World J Gastroenterol 2008; 14:4338-41.
39. Wroblewski D, Hannett GE, Bopp DJ, et al. Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J Clin Microbiol 2009; 47:2142-8.